Another Biotech Massively Outperforming Broader Equities
27 Décembre 2023 - 3:15PM
AllPennyStocks.com
A California-based biotech company is stealing
the show during Wednesday’s premarket after it was announced that
the FDA approved Udenyca Onbody, a device used to
deliver...
To read the full story on AllPennyStocks.com, click
here.
Coherus BioSciences (NASDAQ:CHRS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Coherus BioSciences (NASDAQ:CHRS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024